Elanco's acquisition of Bayer's animal health business not opposed

THE Australian Competition & Consumer Commission (ACCC) will not oppose Elanco’s acquisition of Bayer AG’s animal health business, after Elanco provided a court-enforceable undertaking to divest four animal parasite treatment brands.

Elanco's acquisition of Bayer's animal health business not opposed Elanco's acquisition of Bayer's animal health business not opposed Elanco's acquisition of Bayer's animal health business not opposed Elanco's acquisition of Bayer's animal health business not opposed Elanco's acquisition of Bayer's animal health business not opposed

Bayer and Elanco are close to sealing to major deal covering a range of animal health products. Image Mark Saunders.

The ACCC had concerns about the effect of the acquisition in the markets for sheep lice treatments, and worming treatments for cats and dogs.

topics

loader

Most read Livestock